- Home
- TAK vs PRU Comparison
TAK vs PRU Comparison
Compare TAK & PRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- PRU
- Stock Information
- Founded
- TAK 1781
- PRU 1875
- Country
- TAK Japan
- PRU United States
- Employees
- TAK N/A
- PRU N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- PRU Life Insurance
- Sector
- TAK Health Care
- PRU Finance
- Exchange
- TAK Nasdaq
- PRU Nasdaq
- Market Cap
- TAK 43.3B
- PRU 36.5B
- IPO Year
- TAK N/A
- PRU N/A
- Fundamental
- Price
- TAK $14.52
- PRU $108.55
- Analyst Decision
- TAK
- PRU Hold
- Analyst Count
- TAK 0
- PRU 12
- Target Price
- TAK N/A
- PRU $120.73
- AVG Volume (30 Days)
- TAK 3.3M
- PRU 1.9M
- Earning Date
- TAK 10-30-2025
- PRU 10-29-2025
- Dividend Yield
- TAK 1.90%
- PRU 5.00%
- EPS Growth
- TAK N/A
- PRU N/A
- EPS
- TAK 0.14
- PRU 7.27
- Revenue
- TAK $29,846,840,032.00
- PRU $57,598,000,000.00
- Revenue This Year
- TAK $0.01
- PRU N/A
- Revenue Next Year
- TAK $0.49
- PRU $3.85
- P/E Ratio
- TAK $104.21
- PRU $14.85
- Revenue Growth
- TAK N/A
- PRU N/A
- 52 Week Low
- TAK $12.80
- PRU $90.38
- 52 Week High
- TAK $15.69
- PRU $130.55
- Technical
- Relative Strength Index (RSI)
- TAK 62.71
- PRU 62.95
- Support Level
- TAK $14.01
- PRU $101.22
- Resistance Level
- TAK $14.56
- PRU $107.94
- Average True Range (ATR)
- TAK 0.17
- PRU 1.93
- MACD
- TAK 0.08
- PRU 0.26
- Stochastic Oscillator
- TAK 95.50
- PRU 93.70
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About PRU Prudential Financial Inc.
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2024 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 40% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 10% of its 2024 adjusted earnings and has around $1.4 trillion in assets under management.